HomeComparePKBO vs PLD

PKBO vs PLD: Dividend Comparison 2026

PKBO yields 8888.89% · PLD yields 3.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PKBO wins by $17290949737713794.00M in total portfolio value
10 years
PKBO
PKBO
● Live price
8888.89%
Share price
$0.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$17290949737713800.00M
Annual income
$16,916,578,202,775,594,000,000.00
Full PKBO calculator →
PLD
PLD
● Live price
3.10%
Share price
$132.18
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.91M
Annual income
$4,750,725.19
Full PLD calculator →

Portfolio growth — PKBO vs PLD

📍 PKBO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPKBOPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PKBO + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PKBO pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PKBO
Annual income on $10K today (after 15% tax)
$755,555.56/yr
After 10yr DRIP, annual income (after tax)
$14,379,091,472,359,256,000,000.00/yr
PLD
Annual income on $10K today (after 15% tax)
$263.66/yr
After 10yr DRIP, annual income (after tax)
$4,038,116.41/yr
At 15% tax rate, PKBO beats the other by $14,379,091,472,359,252,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PKBO + PLD for your $10,000?

PKBO: 50%PLD: 50%
100% PLD50/50100% PKBO
Portfolio after 10yr
$8645474868856903.00M
Annual income
$8,458,289,101,387,799,000,000.00/yr
Blended yield
97.83%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

PKBO
No analyst data
Altman Z
13837.7
Piotroski
4/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+2.9% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PKBO buys
0
PLD buys
0
No recent congressional trades found for PKBO or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPKBOPLD
Forward yield8888.89%3.10%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$17290949737713800.00M$5.91M
Annual income after 10y$16,916,578,202,775,594,000,000.00$4,750,725.19
Total dividends collected$17265985963886318.00M$5.78M
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: PKBO vs PLD ($10,000, DRIP)

YearPKBO PortfolioPKBO Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$899,589$888,888.89$11,241$540.96+$888.3KPKBO
2$75,694,763$74,732,202.61$13,019$991.13+$75.68MPKBO
3$5,957,858,933$5,876,865,536.53$15,801$1,870.97+$5957.84MPKBO
4$438,676,028,838$432,301,119,780.33$20,609$3,701.21+$438676.01MPKBO
5$30,217,280,421,144$29,747,897,070,286.80$29,919$7,867.97+$30217280.39MPKBO
6$1,947,399,451,993,550$1,915,066,961,942,926.00$50,631$18,617.74+$1947399451.94MPKBO
7$117,429,004,658,116,600$115,345,287,244,483,520.00$105,528$51,352.20+$117429004658.01MPKBO
8$6,625,994,131,926,989,000$6,500,345,096,942,805,000.00$287,364$174,449.42+$6625994131926.70MPKBO
9$349,879,939,194,586,330,000$342,790,125,473,424,500,000.00$1,081,760$774,280.77+$349879939194585.25MPKBO
10$17,290,949,737,713,800,000,000$16,916,578,202,775,594,000,000.00$5,908,209$4,750,725.19+$17290949737713794.00MPKBO

PKBO vs PLD: Complete Analysis 2026

PKBOStock

Peak Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics addressing unmet needs in the areas of oncology and inflammation. The company's proprietary toxin, PH-1 or Thailanstatin, a spliceosome modulator is being used to generate its first pipeline of novel ADC product candidates to address unmet needs in cancer patients. Its lead product candidate, PHP-303, is a small molecule awaiting Phase II dose clinical study in the orphan disease Alpha1 anti-trypsin deficiency (AATD). The company is based in Palo Alto, California.

Full PKBO Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this PKBO vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PKBO vs SCHDPKBO vs JEPIPKBO vs OPKBO vs KOPKBO vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.